Schering-Plough Corporation

Overview

Schering-Plough Corporation was a global pharmaceutical company known for its research and development activities in various therapeutic areas. It became a subsidiary of Merck & Co., Inc. in 2009 following a merger, expanding Merck's portfolio in several therapeutic areas.

Therapeutic areas

API / Drug Master Files

Schering-Plough Corporation holds 0 active (1 total) FDA Type II Drug Master File — identifying it as an active-substance / API supplier. Type II DMFs are filed with the FDA to support the use of an active pharmaceutical ingredient in drug applications.

• MANUFACTURING SITE, FACILITIES, PERSONNEL, AND GENERAL OPERATING PROCEDURES.Inactive1982-05-25

FDA compliance signals

No FDA recalls, Warning Letters, or Form 483 observations are linked to Schering-Plough Corporation in our records. PharmaTek screens the full directory against live FDA enforcement data.